Roundtable
Roundtable
The roundtable discussion will focus on opportunities for clinical trials within the area of respiratory medicine. The Danish government and Trial Nation are keen to enter in dialogue with innovative US companies in order to discuss potential clinical trials in Denmark.
31. October 2023 from 13:00 to 17:30
This is a unique opportunity to network, connect and learn about opportunities to expand your business in Europe through Denmark.
The luncheon & roundtable discussion will be held on:
📍 31st October 2023, in New York
The Trial Nation Respiratory Center in Denmark was established in 2016 and is a network of Danish respiratory research units specializing in sponsor initiated clinical research with medicinal products across all respiratory diseases. The Center facilitates clinical trials conducted in a specialized clinical setting with trained staff, harmonized clinical assessments and specialized diagnostic methods. The center is committed to developing and maintaining Denmark as a preferred country for respiratory clinical research.
The roundtable meeting has limited capacity. Please click on the link to request an invitation. Participation is free.
Denmark has long been a hub for clinical trials and
the unique and fully digitalized country is the ideal test-bed for new
technology. By attending, you'll gain insights into specific opportunities to
sponsor, participate in and conduct clinical trials in Denmark by our two
speakers Marianne Pilgaard, CEO of Trial Nation and Professor. Dr. Charlotte
Suppli Ulrik, Medical Lead of the Trial Nation Center for Respiratory Diseases.
Marianne Pilgaard possesses over 20 years of managerial experience in the field of life science and clinical development, gained at Novo Nordisk. Marianne's most recent role was Biopharm Director, National Sales & Marketing, Novo Nordisk Sweden, and prior to that, she served as the Head of Clinical Research Sweden at Novo Nordisk from 2005 to 2016.
During the period from 1996 to 2005, Marianne held various managerial positions within clinical development, including data management and project management. Concurrently, she actively participated in the development of the Swedish life science platform, Swelife, thus acquiring valuable insights into the strategic development of life science from a public-private perspective.
Charlotte Suppli Ulrik is a professor of medical lung diseases at the University of Copenhagen and a consultant physician at the Department of Respiratory Medicine, Hvidovre Hospital.
She serves as the Head of the Respiratory Research Unit at Hvidovre Hospital, is a Fellow of the European Respiratory Society (ERS), Chairperson of the steering committee of the Danish Respiratory Research Network, Head of Assembly 6 (Environment and Epidemiology) in the ERS, and serves as the leader (and founder) of the Management of Asthma during Pregnancy (MAP) program. Additionally, she is the national lead in EMBARC (European Registry for Patients with Bronchiectasis) and Medical Lead of the Trial Nation Center for Respiratory Diseases.
The roundtable meeting has limited capacity. Please click on the link to request an invitation. Participation is free.
Please contact our special advisors here:
Title: Investment Manager - Life Science & Digital Health
Area: Silicon Valley
Email: [email protected]
Phone: +1 (650) 272-9510
Title: Deputy Director, North America & Senior Investment Manager - Life Sciences & Location Denmark
Area: New York
Email: [email protected]
Phone: +1 (917) 497 1300
